NATERA, INC. Cash and Restricted Cash
NATERA, INC. (NTRA) had Cash and Restricted Cash of $1.09 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.09B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.09B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.08B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.04B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $1.09B 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.09B 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.08B 10-Q · filed 2026-08-07 |
| 2025-09-30 | $1.04B 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.00B 10-Q · filed 2026-08-07 |
| 2025-03-31 | $973.77M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $945.59M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $892.84M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $796.80M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $813.82M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $642.10M 10-K · filed 2026-02-27 |
| 2023-09-30 | $668.71M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $381.11M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $403.15M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $466.09M 10-K · filed 2026-02-27 |
| 2022-09-30 | $57.13M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $91.38M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $158.53M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $84.61M 10-K · filed 2025-02-28 |
| 2021-09-30 | $95.33M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $63.04M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $65.29M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $48.85M 10-K · filed 2024-02-29 |
| 2020-09-30 | $209.53M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $77.38M 10-Q · filed 2021-08-06 |
| 2020-03-31 | $74.20M 10-Q · filed 2021-05-07 |
| 2019-12-31 | $61.98M 10-K · filed 2023-03-01 |
| 2019-09-30 | $51.66M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $29.98M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $34.68M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $51.00M 10-K · filed 2022-02-25 |
| 2018-09-30 | $39.10M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $18.26M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $39.69M 10-Q · filed 2019-05-10 |
| 2017-12-31 | $13.02M 10-K · filed 2021-02-26 |
| 2017-09-30 | $11.60M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $8.24M 10-Q · filed 2018-08-09 |
| 2016-12-31 | $16.69M 10-K · filed 2020-03-02 |
| 2015-12-31 | $30.53M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |